Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

Scientists have developed a new technique which they describe as a “powerful double weapon” to prevent cancer patients losing ...

A new study from the University of Pittsburgh shows for the first time how exercise improves cancer outcomes and enhances ...

Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...